Grant Avenue Capital Launches Helios Clinical Research
New Integrated Clinical Site Organization Led by World-Class Clinical Development Experts Provides Greater and More Equitable Access to High-Quality Research
Grant Avenue Capital, LLC (“Grant Avenue”), a middle market healthcare-focused private equity firm, today announced the launch of Helios Clinical Research (“Helios”), a new integrated clinical site organization that partners with patients, physicians, and biopharma sponsors to optimize clinical research. Helios operates 20 integrated clinical research sites that specialize in vaccines, metabolic, urology, orthopedics, gastroenterology, dermatology, oncology, and broader general medicine across four states, and expects to strategically expand its footprint throughout the U.S. over time.
Helios’s sites support patients by engaging, educating, and providing them with a quality setting to participate in clinical research as a care option, as well as physicians by simplifying the clinical research process to enable them to focus on optimal patient care and data collection. In partnership with biopharma sponsors, Helios expedites the drug approval process, enhancing key delivery components such as study startup, patient recruiting and engagement, and regulatory and quality compliance.
Helios is led by a world-class team of clinical development experts with decades of proven operating experience and a track record of delivering value to clinical research stakeholders, including patients, physicians, and biopharma. The team includes:
E.B. McLindon, Chief Executive Officer – Mr. McLindon brings substantial experience in managing, acquiring, and integrating clinical research sites, most recently serving as Senior Vice President of Site, Patient and Decentralized Solutions at leading global Clinical Research Organization (“CRO”), ICON plc.
Stephen DeCherney, MD, Chairman – A professor of medicine at the University of North Carolina, Chapel Hill, Dr. DeCherney was the former President of the Global CRO at Quintiles Transnational Corporation (now IQVIA), and has also held roles at National Institutes of Health.
Natalie Gassen, Chief Financial Officer and Chief Operating Officer – With nearly three decades of private and public company financial leadership experience, Ms. Gassen has served as CFO at Allucent (formerly Pharm-Olam), ApoCell, Inc., and Triad Resources.
Sergio Armani, Senior Vice President and Head of Business Development – Mr. Armani has significant expertise managing business development activity and CRO sales across large pharmaceutical businesses, most recently serving as Vice President, North American Sponsor & CRO Partnerships-Review Services at Advarra.
Preston Brice, Partner at Grant Avenue, said, “We are launching Helios at a time when the need for a centralized solution to accelerate clinical research has never been greater. By building Helios with best-in-class companies and bringing together individuals we view as the most talented and accomplished in the industry, we believe we are well positioned to deliver a highly optimized solution to patients, physicians, and sponsors. E.B. and Steve are proven industry veterans, backed by a first-rate team, and we look forward to supporting them as Helios executes on its mission of accelerating clinical research and increasing access to potentially life-altering treatment options.”
“The clinical research and development market is hyper-fragmented and requires significant innovation and advancement to best address the needs of patients, physicians and sponsors today,” added Mr. McLindon. “It is for these critical reasons that we created Helios, a company committed to reliably delivering high-quality clinical research data while using technology to streamline time-consuming research processes at the research site, in-turn providing a world-class experience for our patients and physicians. We are pleased to have the backing of Grant Avenue, well-recognized for supporting the growth of exceptional healthcare companies and whose values of truth, grit, teamwork, and community align with those of the Helios team.”
Dr. DeCherney concluded, “We have already formed an expert clinical development team that engages patients and sites across the U.S. to modernize the research experience and help sponsors recruit and retain patients. Looking ahead, we believe the stable foundation of Helios, coupled with the financial and operational support that Grant Avenue provides, will meaningfully differentiate Helios from its competitors and enable us to continue to scale for success long into the future.”
Lincoln International, LLC acted as the financial advisor to Grant Avenue on the formation of Helios.
About Grant Avenue Capital LLC
Founded in 2019, Grant Avenue Capital is a healthcare-focused private equity firm investing alongside forward-thinking management teams seeking an experienced and innovative investor with operational insight and flexible growth capital. Based on underlying sector trends, the Firm pursues opportunities in the middle market, with a focus on companies with approximately $5 million to $25 million of EBITDA across healthcare sub-sectors, including Services, Devices, Pharma & Pharma Services and HCIT. The Firm focuses on control buyouts, buy-and-builds, corporate carve-outs, joint-control partnership investments, and special situations. In addition, the Grant Avenue Foundation supports employees and portfolio companies of Grant Avenue Capital that are actively engaged with healthcare-oriented charitable organizations. For more information, please visit www.grantave.com/.
About Helios Clinical Research
Helios Clinical Research is an integrated clinical site organization that partners with patients, physicians and biopharma sponsors to optimize clinical research. Its world-class clinical development team engages patients and physicians to improve the patients’ research experience, while accelerating the sponsor’s ability to obtain valuable data due to Helios’ expertise in recruiting and retaining patients. Helios’ integrated clinical research sites expedite the drug approval process by focusing on key delivery components such as study startup, patient recruiting and engagement, and regulatory and quality compliance. For more information, please visit www.heliosclinical.com/.
Media Contact:
Amanda Shpiner/Justin Dechiario
Gasthalter & Co.
(212) 257-4170
Grant Avenue Capital Bolsters Investment Team with Addition of Brian Berkin
Seasoned Healthcare Private Equity Professional Joins as Managing Director
Grant Avenue Capital, LLC (“Grant Avenue” or the “Firm”), a lower middle market healthcare-focused private equity firm, today announced that Brian Berkin has joined the Firm as a Managing Director, effective immediately. In this role, Mr. Berkin will be responsible for sourcing and executing investments across Grant Avenue’s subsectors of focus, including Services, Devices, Pharma & Pharma Services, and HCIT.
A seasoned private equity professional with nearly 20 years of experience transacting across middle market healthcare, Mr. Berkin brings significant origination, due diligence, capital raising, and operations experience to Grant Avenue. Throughout the course of his career, he has worked hand-in-glove with management teams to successfully grow their businesses. At Grant Avenue, Mr. Berkin will leverage these skills to help implement the Firm’s portfolio company growth playbook which is based on six core tenets including human capital, operational efficiency, tech enablement, strategic sales and marketing, service or product line expansion, and M&A and de novos.
“Brian is an excellent addition to the Grant Avenue team, as we continue to strategically scale our platform with extraordinary talent,” said Buddy Gumina, Founder and Managing Partner of Grant Avenue. “Since our founding, we have been committed to executing on our mission of investing in and actively building world-class companies that enhance patient health, improve the overall healthcare system, and positively impact communities. I am confident that Brian, who has a proven track record of healthcare investing, deep industry relationships and high integrity, will have a strong impact on Grant Avenue, our portfolio, and our investors for years to come.”
“Grant Avenue is an experienced team of investors who have a passion for backing healthcare companies with solutions that benefit patients and drive long-term company growth,” added Mr. Berkin. “As I step into my new role, I am excited about the significant opportunities that exist in lower middle market healthcare private equity, where I can work with Buddy and the entire Grant Avenue team to apply our thematic approach and growth playbook to build outstanding healthcare enterprises.”
Prior to joining Grant Avenue, Mr. Berkin was a Partner at Tailwind Capital where he coordinated all aspects of the investment process, including developing investment theses, identifying investment talent, managing diligence, structuring transactions, and negotiating term sheets. Previously, he held roles at Chicago Pacific Founders, LLR Partners, and Roundtable Healthcare Partners. Mr. Berkin began his career in investment banking, serving as an analyst at Credit Suisse Group and Bear, Stearns & Co. Inc. He earned a B.A. from the University of Michigan and a Master of Business Administration from The Wharton School at the University of Pennsylvania.
About Grant Avenue Capital LLC
Founded in 2019, Grant Avenue Capital is a healthcare-focused private equity firm investing alongside forward-thinking management teams seeking an experienced and innovative investor with operational insight and flexible growth capital. Based on underlying sector trends, the Firm pursues opportunities in the lower middle market, with a focus on companies with approximately $5 million to $25 million of EBITDA across healthcare sub-sectors, including Services, Devices, Pharma & Pharma Services and HCIT. The Firm focuses on control buyouts, buy-and-builds, corporate carve-outs, joint-control partnership investments, and special situations. In addition, the Grant Avenue Foundation supports employees and portfolio companies of Grant Avenue Capital that are actively engaged with healthcare-oriented charitable organizations. For more information, please visit https://grantave.com/.
Media Contact:
Amanda Shpiner/Justin Dechiario
Gasthalter & Co.
(212) 257-4170
Grant Avenue Capital Expands Advisory Board
Howard Gold and Samantha Bonano expand Grant Avenue constellation of operating executives
Grant Avenue Capital, LLC, www.GrantAve.com, a healthcare-focused private equity firm, announced today that Howard Gold and Samantha Bonano have joined the firm’s Advisory Board, which is comprised of innovative healthcare executives.
“Howard and Samantha are each seasoned healthcare leaders that will bring their significant experience to our Advisory Board and portfolio companies,” said Buddy Gumina, founder and managing partner of Grant Avenue Capital. “In addition, similar to other Advisory Board members, they will actively work with the Grant Avenue Capital team to help identify new investment initiatives.”
Most recently, Howard Gold was an Executive Vice President, Chief Managed Care and Business Development Officer of Northwell Health, New York State’s largest healthcare provider and private employer with 23 hospitals and over 800 outpatient facilities. Prior to joining the health system in 1995, he was vice president-vice provost for strategic planning at The New York Hospital-Cornell Medical Center. Earlier in his career, Howard was executive director of Governor Mario Cuomo’s Health Care Advisory Board and held several healthcare-related positions for New York State.
Samantha Bonano was President and CEO of Buffalo Filter, a leading surgical smoke evacuation and surgical safety devices company, from 2010 to 2019. Under her leadership, Buffalo Filter increased its investment in R&D and new product commercialization, resulting in an acceleration of top-line growth and the sale to Madison Industries / Filtration Group in 2013. Following the sale, Samantha remained CEO of Buffalo Filter and also assumed the role of President of the Medical Device division of Filtration Group. After the sale of Buffalo Filter to ConMed Corporation in 2019, she subsequently served as a Strategic Advisor to the CEO until 2020.
For more information, please visit www.GrantAve.com or email Info@GrantAve.com.
About Grant Avenue Capital LLC
Grant Avenue Capital is a healthcare-focused, middle-market private equity firm targeting investments alongside forward-thinking management teams that seek an experienced and innovative investor with highly flexible capital, both in terms of duration and structure. While a typical investment will involve companies generating approximately $5 million to $25 million of EBITDA, Grant Avenue Capital has significant support to complete larger transactions through strategic co-invest relationships. The firm focuses on control buyouts, buy-and-builds, corporate carve-outs, joint-control partnership investments, and special situations.
Grant Avenue Capital also includes the Grant Avenue Foundation, which supports employees and portfolio companies of Grant Avenue Capital that are actively engaged with healthcare-oriented charitable organizations.
Contact:
Sari E. Ring
Chief of Staff
Grant Avenue Capital
212.294.8935
Fortis Home Health & Hospice Acquires Select Home Health in Partnership with Founders
Most recent acquisition in broader home-based care buy and build initiative
Grant Avenue Capital, LLC, www.GrantAve.com, a healthcare-focused private equity firm, announced today that its portfolio company, Fortis Home Health & Hospice, www.FortisHH.com, acquired Select Home Health, based in Indianapolis, Indiana. The founders of Select reinvested alongside other investors in Fortis as part of the acquisition. Fortis, with operations now in Indiana and Utah, is Grant Avenue Capital’s home-based care buy and build initiative that was launched in December 2020.
Founded by Tim Leonard, Michael Shide, and Michelle Porter in 2010, Select is a highly regarded provider of patient-centered home health and private duty home care services. Additional information about Select is available at www.SelectHHS.com.
This transaction marks the expansion of Fortis into the Midwest region and is a further example of the company’s flexible and partnership-based approach to acquisitions. In addition, the transaction represents the eighth add-on acquisition completed by Grant Avenue Capital in 2021.
In conjunction with the acquisition of Select, Grant Avenue Capital also announced the promotion of Mike Gregory to President & Chief Growth Officer of Fortis. A hospice nurse by background, Mike brings over 16 years of industry experience to the company.
“The founders of Select built their organization to deliver the highest quality of patient care, which is exactly inline with Fortis’ mission and why we are so excited to partner with them,” said Mike Gregory.
“It did not take long for us to realize that Grant Avenue Capital, alongside Fortis, shared our same vision of patient-centered home healthcare,” said Tim Leonard, founder & President of Select. “This partnership will allow our clinicians and support staff to leverage our technology-enabled platforms to provide great care to additional patients across the state.”
“The outstanding team at Select is well known in the market for providing exceptional care to individuals and their families,” said Buddy Gumina, founder and managing partner of Grant Avenue Capital. “We plan to accelerate the expansion of Select and our broader home-based care platform, Fortis, through continued investment in the clinical and leadership teams combined with strategic acquisitions, partnerships and de novo launches.”
For more information, please visit www.GrantAve.com or email Info@GrantAve.com.
About Grant Avenue Capital LLC
Grant Avenue Capital is a healthcare-focused, middle-market private equity firm targeting investments alongside forward-thinking management teams that seek an experienced and innovative investor with highly flexible capital, both in terms of duration and structure. While a typical investment will involve companies generating approximately $5 million to $25 million of EBITDA, Grant Avenue Capital has significant support to complete larger transactions through strategic co-invest relationships. The firm focuses on control buyouts, buy-and-builds, corporate carve-outs, joint-control partnership investments, and special situations.
In addition, the Grant Avenue Foundation supports employees and portfolio companies of Grant Avenue Capital that are actively engaged with healthcare-oriented charitable organizations.
Contact:
Sari E. Ring
Chief of Staff
Grant Avenue Capital
212.294.8935
H2 Health Expands Into Applied Behavior Analysis (ABA)
Grant Avenue Capital, LLC, www.GrantAve.com, a healthcare-focused private equity firm, announced today that its portfolio company, H2 Health, dramatically expanded its pediatric therapy service offerings to include applied behavior analysis (ABA), through the acquisition of Great Strides Rehabilitation, Inc, www.GreatStridesRehab.com.
H2 Health is a national provider of outpatient rehabilitation care offering a wide range of services, including physical, occupational, and speech therapies. Great Strides Rehabilitation provides care to children of all ages with developmental disabilities using a comprehensive interdisciplinary model in a variety of settings throughout Northeast Florida. The addition of Great Strides Rehabilitation will add applied behavior analysis to H2 Health’s continuum of pediatric rehabilitation care offerings. BMO Harris Bank’s Sponsor Finance team provided debt financing and BMO Capital Markets Corp. acted as financial advisor to H2 Health in connection with the transaction.
“I have dedicated my career to improving wellbeing for children and families and believe the partnership with H2 Health will expand the opportunities for Great Strides to complete that mission,” said Great Strides Rehabilitation’s founder, Jon Edenfield OTD, OTR/L.
Guy Sansone, founding partner of Kiawah River Health Partners, a Grant Avenue Capital Advisory Board member and Chairman, CEO and Co-Founder of H2 Health added: “The partnership between H2 Health and Great Strides Rehabilitation strengthens our long-term strategic goal of being the most comprehensive rehab provider for patients of all ages in the communities we serve. H2 intends to add the Great Strides brand of high-quality ABA service to each of its pediatric markets, including Texas, Southern Virginia, Western Kentucky and throughout the state of Florida.”
“The acquisition of Great Strides significantly broadens H2 Health’s suite of therapy services” said Buddy Gumina, founder and managing partner of Grant Avenue Capital. “In addition, the expansion of H2 Health is an excellent example of Grant Avenue Capital’s transformational growth playbook.”
For more information please visit www.GrantAve.com or email Info@GrantAve.com.
About Grant Avenue Capital LLC
Grant Avenue Capital is a healthcare-focused, middle-market private equity firm targeting investments alongside forward-thinking management teams that seek an experienced and innovative investor with highly flexible capital, both in terms of duration and structure. While a typical investment will involve companies generating approximately $5 million to $25 million of EBITDA, Grant Avenue Capital has significant support to complete larger transactions through strategic co-invest relationships. The firm focuses on control buyouts, buy-and-builds, corporate carve-outs, joint-control partnership investments, and special situations.
In addition, the Grant Avenue Foundation supports employees and portfolio companies of Grant Avenue Capital that are actively engaged with healthcare-oriented charitable organizations.
About H2 Health
H2 Health provides comprehensive rehabilitation services to children, adults, and seniors throughout its fast-growing operating network. Located in eight states, H2 owns, operates and manages 108 clinics in communities across the country.
Contact:
Sari E. Ring
Chief of Staff
Grant Avenue Capital
212.294.8935
Grant Avenue Capital Acquires QHR Health
Investing in Independent Community Healthcare
Grant Avenue Capital, LLC, www.GrantAve.com, a healthcare-focused private equity firm, announced today that it acquired a majority interest in QHR Health from Quorum Health Corporation. Terms of the transaction were not disclosed.
Founded in 1977, QHR Health is a leading shared service solutions provider for independent hospitals and health systems nationwide. The Company provides a broad base of solutions, including management advisory services, revenue cycle management, supply chain optimization, outsourced IT services and strategic consulting. Grant Avenue Capital is acquiring the business from Quorum Health Corporation, a leading operator of general acute care hospitals and outpatient services in the U.S. QHR Health will continue to provide Quorum Health Corporation with supply chain support and select consulting services. Additional information about QHR Health is available at www.qhr.com.
This transaction marks Grant Avenue Capital’s seventh corporate carve-out since its launch in 2019 and is a further example of the firm’s operational and execution capabilities.
“This is an exciting time for QHR Health, our clients and the markets we serve,” said Dwayne Gunter president and CEO of QHR Health. “Our partnership with Grant Avenue fuels the ability to accelerate development of our technology-enabled shared-services, expand our human capital capabilities, and provide the solutions our clients require to remain independent, financially strong and well-positioned to serve the evolving healthcare needs of their communities.”
“Strengthening independent community healthcare is foundational to a strong, national healthcare infrastructure,” said Buddy Gumina, founder and managing partner of Grant Avenue Capital. “The QHR team has demonstrated the ability to meaningfully impact and improve the performance of its clients through its broad solution set. We look forward to investing further in QHR, both organically and through acquisitions, to expand its breadth of services.”
Nashville Capital Network and Brentwood Capital Partners also invested in the transaction alongside Grant Avenue Capital. Brentwood Capital Advisors served as the exclusive financial advisor to Grant Avenue Capital.
Churchill Asset Management LLC served as Lead Arranger and Administrative Agent, with First Eagle Alternative Credit, LLC serving as a Joint Lead Arranger.
For more information please visit www.GrantAve.com or email Info@GrantAve.com.
About Grant Avenue Capital, LLC
Grant Avenue Capital is a healthcare-focused, middle-market private equity firm targeting investments alongside forward-thinking management teams that seek an experienced and innovative investor with highly flexible capital, both in terms of duration and structure. While a typical investment will involve companies generating approximately $5 million to $25 million of EBITDA, Grant Avenue Capital has significant support to complete larger transactions through strategic co-invest relationships. The firm focuses on control buyouts, buy-and-builds, corporate carve-outs, joint-control partnership investments, and special situations.
In addition, the Grant Avenue Foundation supports employees and portfolio companies of Grant Avenue Capital that are actively engaged with healthcare-oriented charitable organizations.
About QHR Health
QHR Health is the industry's leading health solutions provider serving independent, critical access and rural hospitals and health systems across the U.S. For more than 40 years, QHR Health has collaborated with clients to ensure that people in communities ranging from small rural towns to larger population centers, have local access to quality healthcare services.
Contact:
Sari E. Ring
Chief of Staff
Grant Avenue Capital, LLC
212.294.8935
Grant Avenue Capital Acquires Valeo Home Health and Hospice
First step in broader home-based care buy and build initiative
Grant Avenue Capital, LLC, www.GrantAve.com, a healthcare-focused private equity firm, announced today that it acquired a majority interest in Valeo Home Health and Hospice, based in Salt Lake City, Utah. The acquisition represents the firm’s first step in a broader home-based care buy and build initiative.
Founded in 2011, Valeo is a highly regarded provider of patient-focused home health and hospice services. Grant Avenue Capital is acquiring the business from Eduro Healthcare, a leading owner and operator of skilled nursing facilities. Certain individual shareholders of Eduro will continue to have a minority ownership stake in Valeo. Additional information about Valeo is available at www.valeohh.com.
This transaction marks Grant Avenue Capital’s fourth corporate carve-out since its launch in 2019 and is a further example of the firm’s operational and execution capabilities.
In conjunction with the acquisition of Valeo, Grant Avenue Capital has launched a broader buy and build initiative to complete targeted acquisitions and strategic partnerships in the home-based care sector. Members of the firm have a long history of successfully investing in the category starting in the early 2000’s and across numerous, industry-leading companies.
“Valeo’s dedicated leadership, operations, and clinical teams provide outstanding care to patients and their families, as exemplified by its expansion of services during 2020 to serve those particularly hard-hit by COVID,” said Buddy Gumina, founder and managing partner of Grant Avenue Capital. “Going forward, we plan to accelerate the expansion of both Valeo and our overall home-based care platform through continued investment in strategic acquisitions, partnerships and de novo launches.”
Grant Avenue Capital was advised on the acquisition by TripleTree, LLC.
For more information please visit www.GrantAve.com or email Info@GrantAve.com.
About Grant Avenue Capital, LLC
Grant Avenue Capital is a healthcare-focused, middle-market private equity firm targeting investments alongside forward-thinking management teams that seek an experienced and innovative investor with highly flexible capital, both in terms of duration and structure. While a typical investment will involve companies generating approximately $5 million to $25 million of EBITDA, Grant Avenue Capital has significant support to complete larger transactions through strategic co-invest relationships. The firm focuses on control buyouts, buy-and-builds, corporate carve-outs, joint-control partnership investments, and special situations.
In addition, the Grant Avenue Foundation supports employees and portfolio companies of Grant Avenue Capital that are actively engaged with healthcare-oriented charitable organizations.
Contact:
Sari E. Ring
Chief of Staff
Grant Avenue Capital, LLC
212.294.8935
H2 Health Expands Platform
Grant Avenue Capital portfolio company significantly grows clinical reach and breadth of patient care
Grant Avenue Capital, LLC, www.GrantAve.com, a healthcare-focused private equity firm, announced today that its portfolio company, H2 Health, has significantly expanded its clinical reach over the course of 2020 through a combination of increasing the employee base, executing strategic partnerships, and opening de novo locations.
H2 Health Physical Therapy is a national provider of outpatient physical rehabilitation care offering a wide range of services, including physical, occupational, and speech therapies. Over the course of 2020, the business grew its outpatient clinic base by almost 50% to 88 facilities across nine states. Most recently, H2 Health partnered with Greenbrier Valley Physical Therapy in West Virginia. BMO Harris Bank’s Sponsor Finance team provided debt financing and BMO Capital Markets Corp. acted as financial advisor to Grant Avenue Capital in connection with the transaction.
In addition, H2 Health grew its employee base over 20% during 2020. Further information about H2 Health is available at www.H2Health.com.
MileStone, a H2 Health company, provides per-diem, travel, and contract clinical staffing to healthcare providers and facilities throughout the country. MileStone extended its national reach over the course of 2020, providing critical clinical resources to help alleviate facility shortages. Additional information about MileStone is available at www.MileStoneStaffing.com.
“H2 Health has truly established itself as a leading platform and ‘partner-of-choice’ for other companies in the outpatient rehab and caregiver staffing sectors,” said Buddy Gumina, founder and managing partner of Grant Avenue Capital. “In addition, the expansion of H2 Health is an excellent example of Grant Avenue Capital investing in people and implementing its systematic growth playbook.”
Guy Sansone, founding partner of Kiawah River Health Partners, a Grant Avenue Capital Advisory Board member, and Chairman and CEO of H2 Health added: “The dedicated and patient-focused management team, clinicians, and employees of H2 Health have done a fantastic job in 2020 increasing the ability of the company to provide top-notch care to individuals in their communities. In partnership with Grant Avenue Capital, we look forward to further building on our strong foundation during the year ahead.”
For more information, please visit www.GrantAve.com or email Info@GrantAve.com.
About Grant Avenue Capital LLC
Grant Avenue Capital is a healthcare-focused, middle-market private equity firm targeting investments alongside forward-thinking management teams that seek an experienced and innovative investor with highly flexible capital, both in terms of duration and structure. While a typical investment will involve companies generating approximately $5 million to $25 million of EBITDA, Grant Avenue Capital has significant support to complete larger transactions through strategic co-invest relationships. The firm focuses on control buyouts, buy-and-builds, corporate carve-outs, joint-control partnership investments, and special situations.
In addition, the Grant Avenue Foundation supports employees and portfolio companies of Grant Avenue Capital that are actively engaged with healthcare-oriented charitable organizations.
Contact:
Sari E. Ring
Chief of Staff
Grant Avenue Capital
212.294.8935
Grant Avenue Capital Announces Promotions
Alex Ferree and Eric Kim promoted to Vice President
Firm targets two Senior Associate hires for 2021
Grant Avenue Capital, LLC, www.GrantAveCap.com, a New York-based healthcare-focused private equity firm, is pleased to announce the promotions of Alex Ferree and Eric Kim to Vice President.
“Alex and Eric are integral members of the Grant Avenue team. These promotions reflect their demonstrated leadership and strong knowledge of our targeted healthcare sectors,” said Buddy Gumina, Grant Avenue Founder and Managing Partner. “Each of them has contributed meaningfully to the growth of the firm by working alongside our executive teams and Advisory Board members to drive success.”
In addition, the firm expects to hire two Senior Associates in 2021. “We are seeking talented individuals with a passion for healthcare investing who can grow and develop with Grant Avenue over the long term,” remarked Preston Brice, a Grant Avenue Partner.
For more information please visit www.GrantAveCap.com or email Info@GrantAveCap.com. For recruiting inquiries, email JoinTheTeam@grantavecap.com.
About Grant Avenue Capital, LLC
Grant Avenue Capital is a healthcare-focused, middle-market private equity firm targeting investments alongside forward-thinking management teams that seek an experienced and innovative investor with highly flexible capital, both in terms of duration and structure. While a typical investment will involve companies generating approximately $5 million to $25 million of EBITDA, Grant Avenue Capital has significant support to complete larger transactions through strategic co-invest relationships. The firm focuses on control buyouts, buy-and-builds, corporate carve-outs, joint-control partnership investments, and special situations.
In addition, the Grant Avenue Foundation supports employees and portfolio companies of Grant Avenue Capital that are actively engaged with healthcare-oriented charitable organizations.